4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A 1 , A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2I, R4, R5, and R6 are as define d in the detailed description of the invention. Corresponding pharmaceutica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ENNIS, MICHAEL DALTON, TENBRINK, RUTH ELIZABETH, KORTUM, STEVEN WADE
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ENNIS, MICHAEL DALTON
TENBRINK, RUTH ELIZABETH
KORTUM, STEVEN WADE
description Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A 1 , A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2I, R4, R5, and R6 are as define d in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2602227A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2602227A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2602227A13</originalsourceid><addsrcrecordid>eNqNyjEKwjAUANAsDqLe4R_AgKai8zf9Jh_SJKRxqCKlSJxEC_X-uHgAp7e8uUg7GTlSwgv7zmXL5ANc1bqS9Q1il7jhmj2BDk0MZ1-3gC1Eh5kcZTQmkcHMwQN7y0fOIbVLMXsMz6msfi4EnChrK8v47ss0DvfyKp9eo9pvlFIH3FZ_lC-YWi9m</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS</title><source>esp@cenet</source><creator>ENNIS, MICHAEL DALTON ; TENBRINK, RUTH ELIZABETH ; KORTUM, STEVEN WADE</creator><creatorcontrib>ENNIS, MICHAEL DALTON ; TENBRINK, RUTH ELIZABETH ; KORTUM, STEVEN WADE</creatorcontrib><description>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A 1 , A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2I, R4, R5, and R6 are as define d in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061005&amp;DB=EPODOC&amp;CC=CA&amp;NR=2602227A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061005&amp;DB=EPODOC&amp;CC=CA&amp;NR=2602227A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ENNIS, MICHAEL DALTON</creatorcontrib><creatorcontrib>TENBRINK, RUTH ELIZABETH</creatorcontrib><creatorcontrib>KORTUM, STEVEN WADE</creatorcontrib><title>4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS</title><description>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A 1 , A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2I, R4, R5, and R6 are as define d in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwjAUANAsDqLe4R_AgKai8zf9Jh_SJKRxqCKlSJxEC_X-uHgAp7e8uUg7GTlSwgv7zmXL5ANc1bqS9Q1il7jhmj2BDk0MZ1-3gC1Eh5kcZTQmkcHMwQN7y0fOIbVLMXsMz6msfi4EnChrK8v47ss0DvfyKp9eo9pvlFIH3FZ_lC-YWi9m</recordid><startdate>20061005</startdate><enddate>20061005</enddate><creator>ENNIS, MICHAEL DALTON</creator><creator>TENBRINK, RUTH ELIZABETH</creator><creator>KORTUM, STEVEN WADE</creator><scope>EVB</scope></search><sort><creationdate>20061005</creationdate><title>4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS</title><author>ENNIS, MICHAEL DALTON ; TENBRINK, RUTH ELIZABETH ; KORTUM, STEVEN WADE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2602227A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ENNIS, MICHAEL DALTON</creatorcontrib><creatorcontrib>TENBRINK, RUTH ELIZABETH</creatorcontrib><creatorcontrib>KORTUM, STEVEN WADE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ENNIS, MICHAEL DALTON</au><au>TENBRINK, RUTH ELIZABETH</au><au>KORTUM, STEVEN WADE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS</title><date>2006-10-05</date><risdate>2006</risdate><abstract>Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula (I) wherein A 1 , A2, A3, A4, A5, A6, A7, A8, X4, X6, R2k, R2I, R4, R5, and R6 are as define d in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2602227A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title 4-PIPERAZINYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELETAGGREGATION INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ENNIS,%20MICHAEL%20DALTON&rft.date=2006-10-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2602227A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true